Paula Soteropoulos

CIK 1692444 · Chief Executive Officer · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$557.0K

Companies

4

Total Filings

39

Lifetime Open-Market Net

-$5.79M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DNTH Director 0 $82.07 $0 -$2.25M 7 2026-05-22
RLYB Director $15.92 $0 5 2025-05-15
QURE Director 20,203 $27.57 $557.0K -$1.92M 22 2024-06-17
AKCEA THERAPEUTICS, INC. (AKCA) Delisted Chief Executive Officer 1,711,079 -$1.61M 5 2019-09-30

Recent Filings · Page 3 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-01-05 RLYB Grant (A) $0 EDGAR
2021-03-04 QURE Sell (S) −504 -$19.0K EDGAR
2021-03-01 QURE Grant (A) +2,382 $0 EDGAR
2020-03-02 QURE Grant (A) +2,063 $0 EDGAR
2020-02-05 QURE Sell (S) −2,122 -$129.3K EDGAR
2020-01-30 QURE Sell (S) −807 -$50.2K EDGAR
2020-01-08 QURE Sell (S) −3,000 -$216.5K EDGAR
2019-12-17 QURE Mixed -$130.3K EDGAR
2019-12-09 QURE Sell (S) −11,582 -$752.3K EDGAR
2019-09-30 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Mixed +678,149 -$8.49M EDGAR
Showing 2130 of 39
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.